文献速递认知障碍与痴呆神经免疫

顺磁性边缘病灶与放射学孤立综合征发展为临床多发性硬化的关联

Paramagnetic Rim Lesions and Development of Clinical MS in Radiologically Isolated Syndrome.
PubMed 文献 · JAMA Neurol · 2026-01-01

这项多中心前瞻性队列研究纳入79例放射学孤立综合征(RIS)患者,评估3-T MRI中顺磁性边缘病灶(PRL)和中央静脉征阳性病灶(CVS+L)对临床多发性硬化(MS)的预测价值。结果显示PRL数量越多,症状出现越早,且PRL与临床MS风险显著相关,提示慢性活动性炎症可预测RIS向MS转化。

要点

  • PRL数量增加与RIS患者症状出现提前独立相关,并在验证队列中重复验证。
  • 发现队列中≥4个PRL或PRL计数更高可预测临床MS,验证队列中任意PRL均与临床MS相关。
  • PRL作为慢性活动性脱髓鞘的影像标志,有助于指导RIS患者的治疗决策。

核心结论

  • 白质病灶内持续存在的慢性炎症(以PRL为标志)预示RIS患者将发展为临床MS。

研究设计与样本

  • 多中心前瞻性队列研究,2011至2024年从3个大型学术MS中心连续纳入79例符合已发表RIS标准的>18岁患者,分为发现队列36例和验证队列43例。

主要发现

  • 发现队列中9/36(25%)发展为MS,中位时间5.2年;验证队列中9/43(21%)发展为MS,中位时间4.4年。

临床怎么用

  • 对RIS患者进行3-T MRI评估PRL数量,可能有助于识别临床MS高风险者并指导早期治疗决策。
  • PRL作为慢性活动性脱髓鞘标志,支持将无症状MS纳入诊断标准的讨论。

局限性

  • 发现队列初始46例中10例退出或失访,可能影响结果稳定性。
  • 样本量较小(共79例),部分估计值置信区间较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Most people with radiologically isolated syndrome (RIS) have high proportions of white matter lesions (WMLs) demonstrating the central vein sign (ie, central vein sign-positive lesion [CVS+L]) and at least 1 paramagnetic rim lesion (PRL), representing perivenular lesion development and chronic active demyelination, respectively. Whether these imaging measures predict developing clinical multiple sclerosis (MS) in people with RIS is not yet known. OBJECTIVE: To determine the prognostic value of various magnetic resonance imaging (MRI) measures, particularly PRLs and CVS+L, in predicting clinical MS in people with RIS. DESIGN, SETTING, AND PARTICIPANTS: This was a multicenter prospective cohort study conducted from 2011 and 2024. Participants older than 18 years and fulfilling published RIS criteria were consecutively recruited from 3 large academic MS centers. EXPOSURES: Participants underwent 3-T MRI including brain and spinal cord (SC) sequences and longitudinal clinical assessments. MRIs were evaluated for the total WML, PRL, and SC lesion (SCL) counts as well as the proportion of CVS+L. MAIN OUTCOMES AND MEASURES: The primary outcome was the development of clinical symptoms of MS. Time-varying Cox regression assessed the association between PRLs and symptom onset. Elastic net regression identified key predictors, incorporating PRLs, age, sex, and SCL. RESULTS: A total of 79 eligible people with RIS were included (36 [46%] in the discovery cohort [DC], 43 [54%] in the validation cohort [VC]). Of the initial 46 DC participants, 10 withdrew or were lost to follow-up, whereas all VC participants completed follow-up. In the DC (median [IQR] age, 40 [31-51] years; 25 female [70%]; median [IQR] follow-up, 6.4 [5.0-9.1] years), 9 of 36 people with RIS (25%) developed MS (median [IQR] time, 5.2 [5.0-6.8] years). In the VC (median [IQR] age, 43 [36-51] years; 23 female [53%]; median [IQR] follow-up, 4.4 [2.5-7.9] years), 9 of 43 people with RIS (21%) developed MS (median [IQR] time, 4.4 [2.5-4.7] years). Higher PRL count was associated with earlier symptom onset between 5 and 30 years after initial RIS diagnosis (hazard ratio [HR], 1.15; 95% CI, 1.05-1.26; P = .004) in the DC, replicated in the VC (HR, 1.51; 95% CI, 1.00-2.27; P = .04). In the DC, having 4 or more PRLs (odds ratio [OR], 14.64; 95% CI, 2.00-207.23; P = .02) and higher PRL count (OR, 1.15; 95% CI, 1.03-1.32; P = .02) predicted clinical MS. In the VC, having any PRL was significantly associated with developing clinical MS (OR, 20.90; 95% CI, 2.35-533.30; P = .02). CONCLUSIONS AND RELEVANCE: Study findings suggest that accrual of nonresolving chronic inflammation in WML portends development of clinical MS in people with RIS, which may have clinical utility in guiding treatment decisions across the MS spectrum and strengthens the case for including asymptomatic MS in the diagnostic criteria. There is growing recognition that early detection of most chronic neurological diseases is critical to prevent or diminish future disability, and these findings are a specific example of how this principle might operate in practice.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Lim TR, Suthiphosuwan S, Gaitán MI, et al. Paramagnetic Rim Lesions and Development of Clinical MS in Radiologically Isolated Syndrome. JAMA Neurol. 2026. PMID: 41587044. doi:10.1001/jamaneurol.2025.5394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。